Skip to main content

MEJORA DE LA PROTECCION NEURONAL Y CEREBRAL EN EL ICTUS MEDIANTE TECNICAS AVANZADAS DE ADMINISTRACION DE PEPTIDOS PENETRANTES DERIVADOS DE TRKB Y PSD-95

PID2022-137710OB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2022
State Plan 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A brain-accessible peptide modulates stroke inflammatory response and neurotoxicity by targeting BDNF-receptor TrkB-T1 specific interactome

  • Ugalde-Triviño, Lola
  • Tejeda, Gonzalo S.
  • Esteban-Ortega, Gema M.
  • Díaz-Guerra, Margarita
[Methods]: We designed cell-penetrating peptides containing TrkB-T1 isoform-specific sequences to: 1) characterize peptide delivery into rat primary cortical cultures and mice brain cortex; 2) isolate and identify the isoform interactome in basal and in vitro excitotoxic conditions; 3) analyze peptide effects on neuroinflammation and neurotoxicity using primary cultures subjected to excitotoxicity or in vivo in a mouse model of ischemia., [Results]: We identify here the TrkB-T1-specific interactome, poorly described to date, and demonstrate that interference of these protein-protein interactions using brain-accessible TrkB-T1-derived peptides can reduce reactive gliosis and decrease excitotoxicity-induced damage in cellular and animal models of stroke, where treatment reduces the infarct volume in male and female mice., [Conclusions]: The crucial role of TrkB-T1 in modulating microglia and astrocyte reactivity indicates that isoform-derived peptides hold promise for the development of therapies for human stroke and other excitotoxicity-associated pathologies., We acknowledge funding from Agencia Estatal de Investigación (PID2019-105784RB-100/AEI/10.13039/501100011033/FEDER, UE). These results are also part of project PID2022-137710OB-I00 funded by MICIU/AEI/10.13039/501100011033/FEDER, UE. The cost of publication has been paid in part by FEDER funds. A contract was funded associated to project PID2019-105784RB-100 (G.M.E-O) and L.U-T. was recipient of fellowships from Spanish Ministry of Universities "Ayuda del Programa de Formación de Profesorado Universitario" with code FPU22/01248 (2024-2028) and "Ayuda para el Fomento de la Investigación en Estudios de Master-UAM" fellowship from Universidad Autónoma de Madrid (2021-2022)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Retrograde transport of neurotrophin receptor TrkB-FL induced by excitotoxicity regulates Golgi stability and is a target for stroke neuroprotection

  • Esteban-Ortega, Gema M.
  • Torres-Campos, Elena
  • Díaz-Guerra, Margarita
Excitotoxicity, aberrant function of survival pathways dependent on brain-derived neurotrophic factor (BDNF), and disruption of the Golgi complex are shared pathological hallmarks in relevant neurological diseases, including stroke. However, the precise interdependence among these mechanisms is not completely defined, knowledge essential for developing neuroprotective strategies. For ischemic stroke, a leading cause of death, disability, and dementia, interfering with excitotoxicity—the major mechanism of neuronal death in the penumbra area—has shown promising results. We are exploring neuroprotection by promoting survival cascades dependent on the BDNF receptor, full-length tropomyosin-related kinase B (TrkB-FL), as these pathways become aberrant after excitotoxicity. We previously developed MTFL457, a blood-brain barrier (BBB) permeable neuroprotective peptide containing a TrkB-FL sequence, which efficiently prevents excitotoxicity-induced receptor processing and preserves BDNF-dependent pathways in an ischemia model, where it decreases infarct size and improves neurological outcome. In this work, using cellular and animal models, we demonstrate that excitotoxicity-induced TrkB-FL downregulation is secondary to receptor endocytosis, interaction with the endosomal protein hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs), retrograde transport to the Golgi, and subsequent disruption of this organelle. Interestingly, peptide MTFL457 interferes with the TrkB-FL/Hrs interaction and receptor trafficking—processes required for excitotoxic Golgi fragmentation and TrkB-FL cleavage—demonstrating a central role for TrkB-FL in controlling Golgi stability. These results suggest the potential for peptide MTFL457 to preserve the function of this organelle and critical neuronal survival pathways in stroke and possibly other neurodegenerative diseases associated with excitotoxicity., The results are part of projects PID2019-105784RB-100 and PID2022-137710OB-I00 funded by Agencia Estatal de Investigación (MCIN/AEI/10.13039/501100011033/FEDER). GME-O and ET-C were supported, respectively, by contracts included in PID2019-105784RB-100 and PID2022-137710OB-I00 projects., Peer reviewed